Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−10.33 USD
−7.15 M USD
0.00 USD
4.23 M
About Phio Pharmaceuticals Corp.
Sector
Industry
CEO
Robert J. Bitterman
Website
Headquarters
Marlborough
Founded
2011
FIGI
BBG0024FKD97
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
PHIO - long - run up into preclinical data releasePhio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipelin
Phio Pharma Impulsing Down. PHIOWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest,
Another gamble on PHIO going down.Goals 0.71, 0.63. Invalidation at 1.02 .
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mer
PHIOPhio Pharmaceuticals Corp (NASDAQ:PHIO) was one of the biggest winners on Friday as the stock closed up $1.44 on the day with huge volumes. I alerted it when it was trading at 75c as a potential big mover due to its huge cash position and catalyst and it did not disappoint us.
Looking at the tec
$PHIO is gonna fall todayPupm&Dump trading strategy idea.
$PHIO is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,34;
stop-loss — $2,50;
take-profit — $2,02/MOC
Do not view
$PHIO is gonna fall todayPupm&Dump trading strategy idea.
$PHIO is rising without clear preconditions today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,75;
stop-loss — $3,19;
take-profit — $2,
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of PHIO is 2.57 USD — it has increased by 21.59% in the past 24 hours. Watch Phio Pharmaceuticals Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Phio Pharmaceuticals Corp. stocks are traded under the ticker PHIO.
PHIO stock has risen by 150.00% compared to the previous week, the month change is a 98.15% rise, over the last year Phio Pharmaceuticals Corp. has showed a −57.38% decrease.
We've gathered analysts' opinions on Phio Pharmaceuticals Corp. future price: according to them, PHIO price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Watch PHIO chart and read a more detailed Phio Pharmaceuticals Corp. stock forecast: see what analysts think of Phio Pharmaceuticals Corp. and suggest that you do with its stocks.
PHIO reached its all-time high on Mar 14, 2013 with the price of 6,379,560.00 USD, and its all-time low was 0.97 USD and was reached on Apr 8, 2025. View more price dynamics on PHIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PHIO stock is 43.58% volatile and has beta coefficient of 4.10. Track Phio Pharmaceuticals Corp. stock price on the chart and check out the list of the most volatile stocks — is Phio Pharmaceuticals Corp. there?
Today Phio Pharmaceuticals Corp. has the market capitalization of 10.51 M, it has decreased by −16.26% over the last week.
Yes, you can track Phio Pharmaceuticals Corp. financials in yearly and quarterly reports right on TradingView.
Phio Pharmaceuticals Corp. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PHIO net income for the last quarter is −1.63 M USD, while the quarter before that showed −1.52 M USD of net income which accounts for −6.69% change. Track more Phio Pharmaceuticals Corp. financial stats to get the full picture.
No, PHIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 5 employees. See our rating of the largest employees — is Phio Pharmaceuticals Corp. on this list?
Like other stocks, PHIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Phio Pharmaceuticals Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Phio Pharmaceuticals Corp. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Phio Pharmaceuticals Corp. stock shows the neutral signal. See more of Phio Pharmaceuticals Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.